By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • 15 SMA Patients to Test AveXis’ Gene Therapy Candidate in Phase I Clinical Trial – SMA News Today

15 SMA Patients to Test AveXis’ Gene Therapy Candidate in Phase I Clinical Trial – SMA News Today

Friday, 26 February, 2016

15 SMA Patients to Test AveXis’ Gene Therapy Candidate in Phase I Clinical Trial – SMA News Today

AveXis, Inc., announced that its Phase 1 clinical trial of its proprietary gene therapy candidate, AVXS-101, for the treatment of spinal muscular atrophy (SMA) Type 1 has now completed patient enrollment. Fifteen young patients, diagnosed before age ...

Read More

Source:15 SMA Patients to Test AveXis' Gene Therapy Candidate in Phase I Clinical Trial - SMA News Today

Categories :
  • Latest Headlines
  • Spinal muscular atrophy
  • Uncategorized
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved